US equities |
NVDA $240.49 ▲+0.67% SPCX $173.81 ▲+1.59% MU $1,065.54 ▲+0.15% MRVL $284.45 ▲+4.87% AMD $656.16 ▲+3.86% INTC $114.24 ▼-1.68% SNDK $1,670.76 ▼-1.96% AVGO $377.64 ▲+4.17%
FinancialContent

Latest News about Bexson Biomedical

Recent news which mentions Bexson Biomedical

EXCLUSIVE: Ketamine Therapy Leaders Share Bold Vision For Future At Benzinga's Psychedelics Capital Conference
Tickers RVLWF
Tags Healing Maps Jeffrey Becker Legal
From Benzinga
New At-Home Multiple Drugs Formulation Delivery Technology Scores US Patent
Tags USPTO Jeffrey Becker Gregg Peterson
From Benzinga
EXCLUSIVE: Bexson Biomedical's CSO Says Subcutaneous Ketamine Could Treat Wide Range Of Health Issues
Tags General Cannabis Ketamine
From Benzinga
EXCLUSIVE: Bexson Biomedical Inks Agreement With Stevanato For Delivery System Of Ketamine In Pain Management
Tags Stevanato Group General drug delivery solutions
From Benzinga